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OBJECTIVES This study sought to assess gender-based differences in long-term outcome after very early
aggressive revascularization for non–ST-elevation acute coronary syndromes (NSTACS).
BACKGROUND The Fragmin and fast Revascularization during InStability in Coronary artery disease
(FRISC) II study suggested that women have less to gain from an early invasive strategy.
METHODS We conducted a prospective cohort study in 1,450 consecutive patients with NSTACS
undergoing coronary angiography and subsequent coronary stenting of the culprit lesion as
the primary revascularization strategy within 24 h of admission. The combined primary end
point was defined as death or nonfatal myocardial infarction (MI) and recorded for a mean
of 20 months.
RESULTS Percutaneous coronary intervention was performed in more than 50% of patients in women
and men and accompanied with stenting in 80%. The percutaneous coronary intervention:
coronary artery bypass grafting ratio was 4:1 in men and 5:1 in women. The primary end point
occurred in 29 (7.0%) women as compared with 108 (10.5%) men (hazard ratio for women,
0.65; 95% confidence interval [CI] 0.42 to 0.99; p  0.045). Backward-stepwise multivariate
Cox regression analysis identified female gender as an independent predictor of death or MI
(hazard ratio for female gender, 0.51; 95% CI, 0.28 to 0.92; p  0.024). Kaplan-Meier
analysis showed that women had consistently lower event rates during the entire follow-up
period (p  0.037 by log-rank for death or MI).
CONCLUSIONS Women treated with very early aggressive revascularization with coronary stenting of the
culprit lesion as the primary revascularization strategy have a better long-term outcome as
compared with men. (J Am Coll Cardiol 2002;40:245–50) © 2002 by the American
College of Cardiology Foundation
Coronary artery disease (CAD) is the leading cause of
morbidity and mortality in both women and men. The
percentage of female patients is rising and was 43% in 1995
(1). Observational studies (2–13) have shown a worse
in-hospital and long-term outcome for acute myocardial
infarction (MI) in women as compared with men. It is
currently unknown whether these differences reflect differ-
ences in baseline characteristics (2–16), pathophysiologic
distinctions (17–21) or gender differences in the diagnosis
and treatment of CAD (2,3,6,22–27) to the detriment of
women.
Each year, 1.5 million patients are hospitalized for acute
coronary syndromes (ACS) in the U.S. An increased risk of
death and recurrent MI has consistently been reported for
women treated with fibrinolysis for ST-elevation ACS
(2–13,15). For non–ST-elevation acute coronary syndromes
(NSTACS), recent studies (14–16,28) have been contro-
versial. In the Fragmin and fast Revascularization during
InStability in Coronary Artery Disease (FRISC) II study
(16), an invasive strategy with coronary angiography within
the first seven days did not reduce the risk of future events
among women, in contrast with its beneficial effect in men.
In fact, multivariate analysis including the presence or
absence of angiographically significant stenoses found fe-
male gender to be an independent risk factor for death or MI.
Very early (within 24 h) revascularization has been
proposed as a novel potentially superior management strategy
in patients with NSTACS (28,29). The long-term outcome of
women as compared with men in NSTACS treated with a very
early invasive strategy remains to be established.
We sought to determine if very early aggressive revascu-
larization with coronary stenting of the culprit lesion as the
primary revascularization strategy might result in identical
outcome for both women and men.
METHODS
Patient population. From January 1996 to December
1999, consecutive patients admitted to our center with
NSTACS were treated with a very early invasive strategy.
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Patients were eligible for inclusion in this study if they had
symptoms of myocardial ischemia occurring at rest (in
general Braunwald class IIIB unstable angina [30]). Patients
with de novo angina pectoris on exertion or worsening
angina during exertion only (Braunwald class 1A to 1C),
patients with persistent ST-elevation and patients with
postinfarction angina (Braunwald class 1C, 2C, 3C) were
excluded. Fifteen patients in whom angiography was not
performed due to patient refusal (n 6) or extremely severe
concomitant disease (n  9) had to be excluded from this
analysis.
The study was carried out according to the principles of
the Declaration of Helsinki. Informed consent was obtained
from all participating patients.
Very early revascularization. Patients with persistent chest
pain underwent immediate coronary angiography. In pa-
tients asymptomatic while on medical therapy, coronary
angiography was performed within 24 h of admission.
Whenever possible, coronary stenting of the culprit lesion
was done directly after angiography. Stenting was not
restricted to patients with one- and two-vessel disease, but
also favored in patients with three-vessel disease, if the
target lesion seemed accessible. If percutaneous coronary
intervention (PCI) was not possible (unprotected left main
disease, diffuse three-vessel disease) but revascularization
seemed necessary, patients were scheduled for urgent coro-
nary artery bypass grafting (CABG).
Follow-up. All patients were scheduled for out-patient
visits at six months. In addition, patients were contacted by
questionnaire in September 2000, nearly five years after
enrollment of the first patient. For patients reporting cardiac
symptoms, at least one clinical and electrocardiographic
examination was performed in the outpatient clinic or by the
referring physician. All information derived from contin-
gent hospital readmission records or provided by the refer-
ring physician or by the outpatient clinic was reviewed and
entered into the computer database.
End points and statistical analysis. The prespecified com-
bined primary end point was defined as death from all
causes or nonfatal MI. Myocardial infarction was defined as
typical chest pain at rest followed by an increase in creatine
phosphokinase (creatine kinase [CK] and CK-MB beyond
two times the upper limit of normal and five times the upper
limit of normal after CABG) or new Q waves in the
electrocardiogram (ECG). All patients received ECG re-
cordings directly after PCI or CABG and on the following
morning. In addition, cardiac markers (CK and CK-MB)
were determined at 8 to 24 h after the intervention and
additionally whenever ischemic symptoms developed. The
statistical analyses were performed using the SPSS/PC
(version 11.0, SPSS Inc., Chicago, Illinois) software pack-
age. Discrete variables were expressed as percentage (95%
confidence interval [CI]), continuous variables as means
(95% CI), and a statistical significance level of 0.05 was
used. Comparisons were made using analysis of variance for
independent samples and chi-square tests as appropriate.
All hypothesis testing was two-tailed. Cox proportional
hazards regression analysis was used as the appropriate
method throughout. Backward-stepwise multivariate Cox
regression analysis was performed to identify independent
predictors of death or MI. Gender, age, previous MI,
previous CABG, previous PTCA, diabetes, mechanical
resuscitation, defibrillation, cardiogenic shock, chest pain
within the last 24 h, non–Q-wave MI, new ST-segment
depression of at least 1 mm, new T-wave inversion,
C-reactive protein 10 mg/l, troponin T  0.1 g/l,
baseline platelet count, baseline creatinine and the number
Table 1. Baseline Patient Characteristics
Women
(n  417)
Men
(n  1,033) p Value
Age (yrs) 68 (67–69) 64 (63–64) 0.01
Prior MI 24 (20–28) 37 (34–40) 0.01
Prior CABG 6 (4–9) 17 (14–19) 0.01
Prior coronary angioplasty 21 (17–25) 24 (21–26) 0.20
Diabetes 23 (18–28) 19 (16–22) 0.15
Hypercholesterolemia 70 (64–76) 68 (64–71) 0.55
Hypertension 72 (66–77) 60 (56–64) 0.01
Smoking 21 (15–26) 33 (30–37) 0.01
Angina pectoris at
rest 48 h
20 (16–24) 16 (14–18) 0.07
Angina pectoris at
rest 48 h
67 (63–72) 69 (66–72) 0.52
Non–Q-wave MI 13 (9–16) 15 (13–17) 0.28
Cardiogenic shock 1 (0–2) 1 (0–2) 0.54
New ST depression at entry 12 (9–15) 10 (8–12) 0.28
New T-wave inversion 34 (29–38) 27 (24–30) 0.01
Troponin T  0.1 g/l 52 (46–58) 58 (54–61) 0.11
CRP  10 mg/l 24 (19–29) 26 (23–30) 0.47
Creatinine (mg/dl) 0.78 (0.73–0.83) 1.00 (0.95–1.05) 0.01
Platelet count (103/l) 248 (241–255) 229 (225–234) 0.01
Data are expressed as mean or percentage (95% confidence interval).
CABG  coronary artery bypass grafting; CRP  C-reactive protein; MI 
myocardial infarction.
Abbreviations and Acronyms
ACS  acute coronary syndromes
CABG  coronary artery bypass grafting
CAD  coronary artery disease
CI  confidence interval
CK  creatine kinase
ECG  electrocardiogram
FRISC  Fragmin and fast
Revascularization during
InStability in Coronary artery
disease study
MI  myocardial infarction
NSTACS  non–ST-elevation acute
coronary syndrome
PCI  percutaneous coronary
intervention
TACTICS-TIMI 18  Treat Angina with Aggrastat
and determine Cost of Therapy
with an Invasive or Conservative
Strategy-Thrombolysis In
Myocardial Infarction 18 trial
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of coronary vessels with 50% stenosis at angiography were
entered into the model. The cumulative survival curves were
constructed with the use of the Kaplan-Meier method.
RESULTS
There were 417 women and 1,033 men in this study (Tables
1 and 2). Baseline characteristics were considerably different
between women and men. The women were significantly
older and less often had prior MI or prior CABG. More
women had arterial hypertension and more men were
smokers. At admission, there was no difference in the rate of
ST-segment depression. However, T-wave inversion was
seen more often in women. Troponin T was elevated in
more than 50% of patients in both groups. Serum creatinine
was lower and platelet count higher in women. There were
more patients without a high-grade coronary lesion among
the women, and less patients with three-vessel disease.
Accordingly, CABG was chosen more often in men (15%
vs. 11%, p  0.02) and medical therapy more often in
women (36% vs. 28%, p  0.01). Percutaneous coronary
intervention was performed in more than 50% of patients of
both genders, and accompanied with stenting in 80%. All
together, two-thirds of patients underwent revasculariza-
tion. The PCI:CABG ratio was 4:1 in men and 5:1 in
women.
Eighty-three deaths and 59 MIs occurred during a mean
follow-up of 20 months (range, 1 to 60). The combined
primary end point of death or MI was recorded in 29 (7.0%)
women as compared with 108 (10.5%) men (Table 3).
Therefore, the risk of death or MI was significantly lower
for women (hazard ratio, 0.65; 95% CI, 0.42 to 0.99; p 
0.045). Total mortality was 4.1% in women as compared
with 6.4% in men (hazard ratio, 0.62; 95% CI, 0.23 to 1.66;
pNS). The incidence of nonfatal MI was 3.1% in women
versus 4.5% in men (hazard ratio, 0.66; 95% CI, 0.34 to
1.28; p  NS). During the in-hospital phase, there was a
trend in favor of women; however, none of the outcome
differences reached statistical significance.
Backward-stepwise multivariate Cox regression analysis
including baseline characteristics, ECG findings, markers of
inflammation and myocardial necrosis, as well as the angio-
graphic extent of CAD identified female gender as an
independent predictor of death or MI (Table 4). In this
model, female gender had a major impact with an hazard
ratio of 0.51 (95% CI, 0.28 to 0.92; p  0.02).
Kaplan-Meier curves for the cumulative probability of
death (Fig. 1) and the cumulative probability of death or MI
(Fig. 2) were considerably different for women and men.
Women had consistently lower event rates during the whole
follow-up period (p 0.0899 by log-rank test for death and
p  0.0366 by log-rank test for death or MI).
DISCUSSION
This study of 1,450 consecutive patients with NSTACS
treated with an aggressive revascularization strategy showed
important differences in baseline clinical characteristics be-
Table 2. Baseline Angiographic and Procedural Characteristics
Women
(n  417)
Men
(n  1,033) p Value
Coronary vessels with 50% stenosis 0.01
0 21 (17–25) 11 (9–13) 0.01
1 26 (22–31) 24 (22–27) 0.45
2 24 (20–29) 23 (20–25) 0.44
3 29 (24–33) 42 (39–46) 0.01
Percutaneous coronary intervention 53 (48–58) 56 (53–59) 0.27
Proportion with stent 80 (74–85) 80 (76–83) 0.97
Proportion with glycoprotein IIb/IIIA inhibition 14 (9–19) 11 (7–15) 0.55
Coronary artery bypass grafting 11 (8–14) 15 (13–17) 0.02
Medical therapy 36 (32–41) 28 (26–31) 0.01
Data are expressed as mean or percentage (95% confidence interval).
Table 3. Association Between Female Gender and Outcome
Women
(n  417)
Men
(n  1,033)
Hazard Ratio
(95% CI) p Value
In-hospital
Death or MI 3.8 (2.0–5.7) 4.7 (3.4–5.9) 0.81 (0.44–1.48) 0.496
Death 1.2 (0.2–2.3) 2.0 (1.2–2.9) 0.64 (0.38–1.10) 0.105
Q-wave MI 0.7 (0.0–1.5) 0.3 (0.0–0.6) 2.49 (0.50–12.36) 0.263
Non–Q-wave MI 1.9 (0.6–3.2) 2.3 (1.4–3.2) 0.75 (0.30–1.86) 0.530
During follow-up
Death or MI 7.0 (4.5–9.4) 10.5 (8.6–12.3) 0.65 (0.42–0.99) 0.045
Death 4.1 (2.2–6.0) 6.4 (4.9–7.9) 0.62 (0.23–1.66) 0.346
MI 3.1 (1.5–4.8) 4.5 (3.2–5.7) 0.66 (0.34–1.28) 0.219
Data are expressed as percentage (95% confidence interval [CI]).
MI  myocardial infarction.
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tween women and men. Most importantly, women were
older but less often had prior MI or prior CABG. In
addition, the angiographic extent of CAD was less severe in
women. These findings are consistent with various previous
studies (2–16). The treatment strategy applied in our patient
is novel in two aspects: 1) timing and 2) preferred method
of revascularization. Coronary angiography and subsequent
coronary stenting of the culprit lesion as the primary
revascularization method were performed within 24 h of
admission in all patients. The PCI:CABG ratio was 4:1 in
men and 5:1 in women. This treatment was associated with
a significantly better long-term outcome in women as
compared with men.
Our analysis has four particular strengths. First, it is
derived from a prospective study of consecutive unselected
patients rather than a randomized trial. This eliminates
selection bias and eases the extrapolation of findings into
clinical practice. Women are notoriously underrepresented
in randomized controlled trials (31) of NSTACS. There-
fore, this prospective study in consecutive patients may be
particular valuable for the investigation of gender-based
differences. Second, it includes long-term follow-up. Third,
a uniform revascularization strategy was applied in all
patients. Fourth, the extent of CAD was quantified in all
patients and included in the multivariate analysis as a
potential cofounder. This enables us to investigate the
impact of female gender independent of the extent of CAD.
Our patient cohort with NSTACS seems similar to the
patients included in the FRISC II (16) and Treat angina
with Aggrastat and determine Cost of Therapy with an
Invasive or Conservative Strategy (TACTICS) (28) studies.
The FRISC II study excluded patients with previous
CABG and patients with advanced age. However, most
baseline patient characteristics were comparable. Three-
vessel disease was present in 38% of patients in this study, as
compared with 23% in FRISC II and 34% in TACTICS,
prior MI in 33% of patients in this study, as compared with
23% in FRISC II and 39% in TACTICS, and a troponin T
0.1 g/l in 56% of patients in this study, as compared with
58% in FRISC II and 54% in TACTICS.
Comparison with FRISC II. The outcome of women in
our study is in marked contrast with the results of the
revascularization strategy used in FRISC II (16). With
coronary angiography performed within the first seven days
and a PCI:CABG ratio of 1:1, women randomized to the
invasive strategy had a worse outcome as compared with
men. In fact, in multivariate analysis, female gender in-
Table 4. Independent Predictors of Death or Myocardial
Infarction During Follow-Up in Multivariate Analysis
Hazard Ratio
(95% CI)
p
Value
Female gender 0.51 (0.28–0.92) 0.024
CRP  10 mg/l 2.43 (1.55–3.81) 0.001
Coronaries with 50% stenosis 1.52 (1.11–4.29)* 0.001
Serum creatinine 1.21 (1.04–1.41) 0.016
Age 1.05 (1.03–1.08)* 0.001
Platelet count 1.004 (1.001–1.006)* 0.002
T-wave inversion 0.51 (0.28–0.91) 0.024
*For an increase in age of 1 year, serum creatinine of 1 mg/dl, platelet count of 103/l
and one coronary with 50% stenosis.
CI  confidence interval; CRP  C-reactive protein.
Figure 1. Cumulative probability of death for women and men during long-term follow-up.
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creased the risk for death or MI (hazard ratio, 1.7; p 
0.014) in the invasive group in FRISC II. This difference
seemed solely due to an excess hazard in women undergoing
CABG. Therefore, the PCI:CABG ratio of the revascular-
ization strategy seems to be an important contributor to
gender differences in the outcome of patients with
NSTACS. In fact, with PCI-based very early revasculariza-
tion, female gender was found to be a significant indepen-
dent predictor of event-free survival. In multivariate analy-
sis, female gender reduced the risk of death or MI by 49%.
Comparison with TACTICS-Thrombolysis In Myocar-
dial Infarction (TIMI) 18. In addition to our findings,
there are other contemporary data (28) that do not support
the conclusion of the FRISC II study, that “women have
less to gain from an early invasive strategy.” The
TACTICS-TIMI 18 trial (28) compared an early invasive
strategy, which included routine catheterization within 4 h
and 48 h and revascularization as appropriate with a
selectively invasive strategy, in which catheterization was
performed if the patient had objective evidence of recurrent
ischemia or an abnormal stress test. The primary end point,
a composite of death, nonfatal MI and rehospitalization for
an acute coronary syndrome at six months, was reduced with
the use of the early invasive strategy in both men and
women. However, the event rate was slightly higher in
women as compared with men (17.0% vs. 15.3%, p  NS).
Of note, the PCI:CABG ratio was 2:1 in the TACTICS-
TIMI 18 trial. This supports our hypothesis of a direct
relation between the PCI:CABG ratio and the relative
outcome of women as compared with men.
The timing of the revascularization procedure may be
another important contributor to gender differences in the
outcome of patients with NSTACS. Several pathophysio-
logic distinctions (17–21) have been reported between
women and men. Women seem to form less coronary
collaterals as compared with men (20). Therefore, they may
benefit particularly from a rapid correction of the epicardial
obstruction during NSTACS. In addition, the benefit of
extended antithrombotic treatment before revascularization
may well be different for women and men (17–19).
Conclusions. Women treated with very early aggressive
revascularization with coronary stenting of the culprit lesion
as the primary revascularization strategy have a better
long-term outcome as compared with men. In multivariate
analysis, female gender independently reduced the risk of
death or MI by 49%.
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